[96a5a0]: / output / allTrials / identified / NCT03892720_identified.json

Download this file

265 lines (265 with data), 11.7 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
{
"info": {
"nct_id": "NCT03892720",
"official_title": "A Phase II Study of Non-Coplanar SBRT Re-Irradiation Using HyperArc in Patients With Recurrent Head and Neck Cancer",
"inclusion_criteria": "* Histologically confirmed recurrent head and neck cancer; either unresectable or status post salvage surgery.\n* History of radiation therapy for head and neck cancer with minimum 50% overlap of the 50% isodose line from prior treatment to the proposed treatment volume.\n* Estimated life expectancy > 12 weeks.\n* Karnofsky performance status >= 70 (Eastern Cooperative Oncology Group [ECOG] 0-2).\n* Maximum tumor, or tumor bed, diameter < 5 cm.\n* If a woman is of childbearing potential, a negative serum pregnancy test must be documented. Women of childbearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; or abstinence) for duration of study participation and for up to 4 weeks following the study treatment.\n* Ability to understand and willingness to sign a written informed consent.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologically confirmed recurrent head and neck cancer; either unresectable or status post salvage surgery.",
"criterions": [
{
"exact_snippets": "Histologically confirmed recurrent head and neck cancer",
"criterion": "recurrent head and neck cancer",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": "histologically confirmed"
}
]
},
{
"exact_snippets": "either unresectable or status post salvage surgery",
"criterion": "head and neck cancer resectability",
"requirements": [
{
"requirement_type": "resectability status",
"expected_value": [
"unresectable",
"status post salvage surgery"
]
}
]
}
]
},
{
"line": "* History of radiation therapy for head and neck cancer with minimum 50% overlap of the 50% isodose line from prior treatment to the proposed treatment volume.",
"criterions": [
{
"exact_snippets": "History of radiation therapy for head and neck cancer",
"criterion": "radiation therapy history",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "minimum 50% overlap of the 50% isodose line from prior treatment to the proposed treatment volume",
"criterion": "isodose line overlap",
"requirements": [
{
"requirement_type": "percentage overlap",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "%"
}
}
]
}
]
},
{
"line": "* Estimated life expectancy > 12 weeks.",
"criterions": [
{
"exact_snippets": "Estimated life expectancy > 12 weeks.",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 12,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Karnofsky performance status >= 70 (Eastern Cooperative Oncology Group [ECOG] 0-2).",
"criterions": [
{
"exact_snippets": "Karnofsky performance status >= 70",
"criterion": "Karnofsky performance status",
"requirements": [
{
"requirement_type": "score",
"expected_value": {
"operator": ">=",
"value": 70,
"unit": "N/A"
}
}
]
},
{
"exact_snippets": "Eastern Cooperative Oncology Group [ECOG] 0-2",
"criterion": "Eastern Cooperative Oncology Group (ECOG) performance status",
"requirements": [
{
"requirement_type": "score",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Maximum tumor, or tumor bed, diameter < 5 cm.",
"criterions": [
{
"exact_snippets": "Maximum tumor, or tumor bed, diameter < 5 cm.",
"criterion": "tumor or tumor bed diameter",
"requirements": [
{
"requirement_type": "size",
"expected_value": {
"operator": "<",
"value": 5,
"unit": "cm"
}
}
]
}
]
},
{
"line": "* If a woman is of childbearing potential, a negative serum pregnancy test must be documented. Women of childbearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; or abstinence) for duration of study participation and for up to 4 weeks following the study treatment.",
"criterions": [
{
"exact_snippets": "If a woman is of childbearing potential",
"criterion": "childbearing potential",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "a negative serum pregnancy test must be documented",
"criterion": "serum pregnancy test",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
},
{
"exact_snippets": "Women of childbearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; or abstinence)",
"criterion": "contraception use",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": true
},
{
"requirement_type": "method",
"expected_value": [
"hormonal",
"barrier",
"abstinence"
]
}
]
},
{
"exact_snippets": "for duration of study participation and for up to 4 weeks following the study treatment",
"criterion": "contraception duration",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "for duration of study participation and for up to 4 weeks following the study treatment"
}
]
}
]
},
{
"line": "* Ability to understand and willingness to sign a written informed consent.",
"criterions": [
{
"exact_snippets": "Ability to understand",
"criterion": "cognitive ability",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "willingness to sign a written informed consent",
"criterion": "willingness to consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}